SeekIn paves the way for cancer early detection in low- and middle-income countries
- Written by PR Newswire
OncoSeek® is a revolutionary multi-cancer early detection (MCED) test developed by SeekIn and empowered by AI technology to significantly reduce the false positive rate compared to the conventional clinical method thus increasing the specificity from 56.9% to 92.9%. In all cancer types, the overall sensitivity of OncoSeek®is 51.7%,...
